ARID1A and cancer: While it appears that ARID1A exhibits more frameshift and nonsense mutations associated with cancer, several missense mutations impact protein stability, as delineated in a 2025 study by Goutam et al. They took the five most common missense mutations in the DNA-binding domain of ARID1A and performed experimental and computational analyses to evaluate protein stability.